Impact Factor
3.28
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.45
222 total citations
h5-index
26
h5 depth signal
Cited share
68.8%
44 of 64
Total citations
222
Citation footprint
Metric signal
2.76
External metric anchor
Self-citation
0.9%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
250
Canada
13
Australia
8
Brazil
8
Netherlands
7
Citing Fields of Research
Psychiatry
278
Psychiatry & Psychology
102
Neurosciences
61
Brain Neurological Disorders
21
Health Education & Remote Healthcare
21
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,475
Articles tracked across the journal lifetime
Indexed publication set
64
44 cited publications
Last 12 months
44
4.9 publications/month
Open access share
13.6%
6 OA publications in the last year
Leading citing country
United States
250 citing publications
Leading citing field
Psychiatry
278 citing publications
Latest tracked publication
7 October 2026
10 recent records available
Coverage & Indexing History
v1n1, May-June 1993-
v1n1, May-June 1993-
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Psychiatry & Psychology
Healthcare Policy
Obstetrics/Gynecology
Issuing & Sponsoring Bodies
Contributor
Harvard Medical School. Department of Psychiatry
Broad Categories
Psychiatry
Psychiatry
Anthropology
Psychiatry & Psychology
Palliative Care
Musculoskeletal Disorders
Neuromuscular Disorders
MeSH Descriptors
Psychiatry
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/hrp.0000000000000480
Open DOI
Retinal Biomarkers of Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
Individuals with schizophrenia consistently show thinning retinal layers, which can potentially serve as neural biomarkers. The association between retinal morphology and core symptom domains like cognitive functioning, however, has not ...
02
DOI 10.1097/hrp.0000000000000482
Open DOI
Seclusion and Restraint in Emergency Settings: A Narrative Review
In psychiatry, restraints are considered last resort interventions to manage agitation and aggression. They are sometimes necessary, however, to ensure patient and staff safety. There are several types of restraints, including seclusion ...
03
DOI 10.1097/hrp.0000000000000483
Open DOI
Beyond Reflection: A Culturally Responsive, Mentalization-Based Balint Model for Medical Education
Balint groups are a widely used form of reflective practice in medical education that offer clinicians a structured space to examine the emotional and relational dimensions of patient care. A substantial body of evidence suggests that pa...
04
DOI 10.1097/hrp.0000000000000481
Open DOI
Perinatal Bipolar Disorder Management: Lithium in the Setting of Obstetric Complications
Managing bipolar disorder in the perinatal period relies on psychopharmacologic treatment due to high rates of postpartum recurrence in the absence of mood-stabilizing medications. Lithium is classically recommended for postpartum bipola...
05
DOI 10.1097/hrp.0000000000000479
Open DOI
Genes Do Not Read DSM: Tuberous Sclerosis Complex May Dominate with Multi-Neuropsychiatric Symptoms
Tuberous sclerosis complex (TSC) is a multisystem genetic disorder frequently accompanied by epilepsy and TSC-associated neuropsychiatric disorders. Psychiatric-predominant seizure presentations may, however, delay recognition. This clin...
06
DOI 10.1097/hrp.0000000000000477
Open DOI
What Psychiatry Measures, and What It Misses: Flourishing as a Blind Spot in Patient-Centered Care
In psychiatry, judgments are routinely made that extend beyond symptom assessment and reduction to areas such as functioning, agency, responsibility, relationships, and meaning in life. Yet standard outcome measures focus narrowly on sym...
07
DOI 10.1097/hrp.0000000000000478
Open DOI
MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis
There is a need for new effective treatment options for posttraumatic stress disorder (PTSD), as many people with PTSD do not fully recover despite current treatments. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy (MDMA...
08
DOI 10.1097/hrp.0000000000000476
Open DOI
Using Islamic Mindfulness-Based Interventions as a Compass for Improving Muslim Mental Health Outcomes: A Scoping Review
Objective: Muslim communities in North America face significant mental health challenges that are exacerbated by Islamophobia, social isolation, and spiritual incongruence. Spiritually adapted mindfulness-based interventions (MBIs) tailo...
09
DOI 10.1097/hrp.0000000000000474
Open DOI
Beyond Symptom Recognition: Toward a Comprehensive Multidimensional Framework of Insight in Depression
Insight in psychiatry has historically been defined through symptom awareness, illness attribution, and recognition of need for treatment—constructs developed primarily in the context of psychosis. When applied to major depressive disord...
10
DOI 10.1097/hrp.0000000000000475
Open DOI
Integrative Residential Treatment of Co-Occurring Borderline and Narcissistic Personality Dysfunction: Perspectives from the Gunderson Residence
Individuals with co-occurring borderline personality disorder and narcissistic personality disorder often present with severe emotional dysregulation, interpersonal instability, identity disturbance, and entrenched patterns of shame, vul...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 29, no. 6 (Dec. 2021).
Also issued online.
Issued on behalf of: Harvard Medical School. Dept. of Psychiatry.